The effect of fulvic acid on pre- and postaggregation state of Aβ17-42: Molecular dynamics simulation studies

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1834, Issue 1, 2013, Pages 24-33

  Verma, Sharad ^a   Singh, Amit ^b   Mishra, Abha ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Alzheimer's disease; Amyloid beta peptides; Fulvic acid; Molecular dynamics simulation

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[17-42]; DIMER; FULVIC ACID; NEUROPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; COMPUTER SIMULATION; DIMERIZATION; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG EFFECT; MOLECULAR DOCKING; MOLECULAR DYNAMICS; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN TERTIARY STRUCTURE; REACTION TIME;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BENZOPYRANS; HUMANS; MOLECULAR DYNAMICS SIMULATION; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY;

EID: 84869880658     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2012.08.016     Document Type: Article

References (83)

1. D.J. Selkoe The molecular pathology of Alzheimer's disease Neuron 6 1991 487 498
2. R. Terry Neuropathological changes in Alzheimer disease Prog. Brain Res. 101 1994 383 390
3. J. Hardy, and D. Allsop Amyloid deposition as the central event in the aetiology of Alzheimer's disease Trends Pharmacol. 12 1991 383 388
4. D. Mann Cerebral amyloidosis aging and Alzheimer's disease; a contribution from studies on Down's syndrome Neurobiol. Aging 10 1989 397 399
5. D. Price, R. Tanzi, D. Borchelt, and S. Sisodia Alzheimer's disease: genetic studies and transgenic models Annu. Rev. Genet. 32 1998 461 493
6. F. Van Leuven Single and multiple transgenic mice as models for Alzheimer's disease Prog. Neurobiol. 61 2000 305 312
7. P. Fraser, D. Yang, G. Yu, L. Levesque, M. Nishimura, S. Arawaka, L.C. Serpell, E. Rogaeva, and P. St George-Hyslop Presenilin structure, function and role in Alzheimer disease Biochem. Biophys. Acta 1502 2000 1 15
8. J.P. Cleary, D.M. Walsh, J.J. Hofmeister, G.M. Shankar, M.A. Kuskowski, D.J. Selkoe, and K.H. Ashe Natural oligomers of the amyloid-b protein specifically disrupt cognitive function Nat. Neurosci. 1 2005 79 84
9. G.M. Shankar, S. Li, T.H. Mehta, A. Garcia-Munoz, N.E. Shepardson, I. Smith, F.M. Brett, M.A. Farrell, M.J. Rowan, C.A. Lemere, C.M. Regan, D.M. Walsh, B.L. Sabatini, and D.J. Selkoe Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Nat. Med. 14 2008 837 842
10. M.D. Kirkitadze, G. Bitan, and D.B. Teplow Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies J. Neurosci. Res. 69 2002 567 577
11. H.A. Lashuel, D. Hartley, B.M. Petre, T. Walz, and P.T.J. Lansbury Neurodegenerative disease: amyloid pores from pathogenic mutations Nature 418 2002 291
12. R. Kayed, E. Head, J.I. Thompson, T.M. McIntire, S.C. Milton, C.W. Cotman, and C.G. Glabe Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 2003 486 489
13. E. Gazit The role of prefibrillar assemblies in the pathogenesis of amyloid diseases Drugs Future 29 2004 613 619
14. S. Barghorn, V. Nimmrich, A. Striebinger, C. Krantz, P. Keller, B. Janson, M. Bahr, Martin Schmidt, R.S. Bitner, J. Harlan, E. Barlow, U. Ebert, and Heinz Hillen Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease J. Neurochem. 3 2005 834 847
15. D.L. Brody, S. Magnoni, K.E. Schwetye, M.L. Spinner, T.J. Esparza, N. Stocchetti, G.J. Zipfel, and D.M. Holtzman Amyloid-b dynamics correlate with neurological status in the injured human brain Science 321 2008 1221 1224
16. R. Azriel, and E. Gazit Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide. An experimental support for the key role of the phenylalanine residue in amyloid formation J. Biol. Chem. 276 2001 34156 34161
17. E. Gazit A possible role for p-stacking in self-assembly of amyloid fibrils FASEB J. 16 2002 77 83
18. E. Gazit Global analysis of tandem aromatic octapeptide repeats: the significance of aromatic-glycine motif Bioinformatics 18 2003 880 883
19. M. Reches, and E. Gazit Casting metal nanowires within discrete self assembled peptide nanotubes Science 300 2003 625 627
20. O.S. Makin, E. Atkins, P. Sikorski, J. Johansson, and L.C.M. Serpell Molecular basis for amyloid fibril formation and stability Proc. Natl. Acad. Sci. 102 2005 315 320
21. H. Inouye, D. Sharma, W.J. Goux, and D.A. Kirschner Structure of core domain of fibril-forming PHF/Tau fragments Biophys. J. 90 2006 1774 1789
22. G. Colombo, I. Daidone, E. Gazit, A. Amadei, and A. Di Nola Molecular dynamic simulation of the aggregation of the core-recognition of the islet amyloid polypeptide in explicit water Protection 59 2005 519 527
23. C. Wu, H.X. Lei, and Y. Duan The role of Phe in the formation of well-ordered oligomers of amyloidogenic hexapeptide (NFGAIL) observed in molecular dynamic simulation with explicit solvent Biophys. J. 88 2005 2897 2906
24. G.G. Tartaglia, A. Cavalli, R. Pellarin, and A. Caflisch The role of aromaticity, exposed surfaces and dipole moment in determining protein aggregation rates Prot. Sci. 13 2004 1939 1941
25. D. Zanuy, Y. Porat, E. Gazit, and R. Nussinov Peptide sequence and amyloid formation: molecular simulation and experimental study of a human islet amyloid polypeptide fragment and its analogs Structures 12 2004 439 455
26. Y. Porat, A. Abramowitz, and E. Gazit Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common Chem. Biol. Drug Des. 67 2006 27 37
27. S. Bastianetto, S. Krantic, and R. Quirion Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease Mini Rev. Med. Chem. 5 2008 429 435
28. C. Rivie're, T. Richard, L. Quentin, S. Krisa, J.M. Mérillon, and J.P. Monti Inhibitory activity of stilbenes on Alzheimer's b-amyloid fibrils in vitro Bioorg. Med. Chem. 15 2007 1160 1167
29. A. Frydman-Marom, M. Rechter, I. Shefler, Y. Bram, D.E. Shalev, and E. Gazit Cognitive-performance recovery of Alzheimer's disease model mice by modulation of early soluble amyloidal assemblies Angew. Chem. Int. Ed. 48 2009 1981 1986
30. R. Scherzer-Attali, R. Pellarin, M. Convertino, A. Frydman-Marom, N. Egoz-Matia, S. Peled, M. Levy-Sakin, D.E. Shalev, A. Caflisch, E. Gazit, and D. Segal Complete phenotypic recovery of an Alzheimer's disease model by a quinone-tryptophan hybrid aggregation inhibitor PLoS One 5 2010 e11101
31. A. Cornejo, J.M. Jiménez, L. Caballero, F. Melo, and R.B. Maccioni Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease J. Alzheimers Dis. 27 2011 143 153
32. T. Lü hrs, C. Ritter, M. Adrian, D. Riek-Loher, B. Bohrmann, H. Dobeli, D. Schubert, and R. Riek 3D structure of Alzheimer's amyloid-β(1-42) fibrils PNAS 102 2005 17342 17347
33. X. Yu, and J. Zheng Polymorphic structures of Alzheimer's b-amyloid globulomers PLoS One 6 2011 e20575
34. J. Zhao, Q. Wang, G. Liang, and J. Zheng Molecular dynamics simulations of low-ordered Alzheimer β-amyloid oligomers from dimer to hexamer on self-assembled monolayers Langmuir 27 2011 14876 14887
35. N. Blinov, L. Dorosh, D. Wishart, and A. Kovalenko Association thermodynamics and conformational stability of b-sheet amyloid b(17-42) oligomers: effects of E22Q (Dutch) mutation and charge neutralization Biophys. J. 98 2010 282 296
36. J. Zheng, H. Jang, B. Ma, and R. Nussinov Annular structures as intermediates in fibril formation of Alzheimer Aβ17-42 J. Phys. Chem. B 112 2008 6856 6865
37. H. Jang, F.T. Arce, S. Ramachandran, R. Capone, R. Azimovac, B.L. Kaganc, R. Nussinov, and R. Lal Truncated β-amyloid peptide channels provide an alternative mechanism for Alzheimer's disease and down syndrome PNAS 107 2010 6538 6543
38. G.M. Morris, D.S. Goodsell, R.S. Halliday, R. Huey, W.E. Hart, R.K. Belew, and A.J. Olson Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function J. Comput. Chem. 19 1998 1639 1662
39. S. Verma, A. Singh, and A. Mishra Taxifolin acts as type I inhibitor for VEGFR-2 kinase: stability evaluation by molecular dynamic simulation J. Appl. Pharmacol. Sci. 2 2012 41 46
40. W.L. DeLano The PyMOL molecular graphics system 2004 DeLano Scientific LLC San Carlos, CA, USA (http://www.pymol.org)
41. H.J.C. Berendsen, D. Van der Spoel, and R. Van Drunen GROMACS - a message passing parallel molecular dynamics implementation Phys. Commun. 91 1995 43 56
42. E. Lindah, B. Hess, and D. Van der Spoel Gromacs 3.0: a package for molecular simulation and trajectory analysis J. Mol. Model. 7 2001 306 317
43. A.W. Schuttelkopf, and D.M.F. van Aalten PRODRG: a tool for high-throughput crystallography of protein-ligand complexes Acta Crystallogr. 60 2004 1355 1363
44. W.F. Van Gunsteren, S.R. Billeter, A.A. Eising, P.H. Hunenberger, P.K.H.C. Kruger, A.E. Mark, W.R.P. Scott, and I.G. Tironi Biomolecular Simulation: the GROMOS96 Manual and User Guide 1996 Vdf Hochschulverlag AG Zurich
45. A.R. Hurshman, J.T. White, E.T. Powers, and J.W. Kelly Transthyretin aggregation under partially denaturing conditions is a downhill polymerization Biochemistry 43 2004 7365 7381
46. F. Massi, and J.E. Straub Energy landscape theory for Alzheimer's amyloid beta-peptide fibril elongation Proteins Struct. Funct. Genet. 42 2001 217 229
47. D. Thirumalai, D.K. Klimov, and R.I. Dima Emerging ideas on the molecular basis of protein and peptide aggregation Curr. Opin. Struct. Biol. 13 2003 146 159
48. G. Tiana, F. Simona, R.A. Brogliaa, and G. Colombo Thermodynamics of beta-amyloid fibril formation J. Chem. Phys. 120 2004 8307 8317
49. E.T. Powers, and D.L. Powers The kinetics of nucleated polymerizations at high concentrations: amyloid fibril formation near and above the "supercritical concentration" Biophys. J. 91 2006 122 132
50. Y.L. Zhao, and Y.D. Wu A theoretical study of beta-sheet models: is the formation of hydrogen bond networks cooperative J. Am. Chem. Soc. 124 2002 1570 1571
51. R.D. Hills, and C.L. Brooks Hydrophobic cooperativity as a mechanism for amyloid nucleation J. Mol. Biol. 368 2007 894 901
52. T.S. Burkoth, T.L.S. Benzinger, V. Urban, D.M. Morgan, D.M. Gregory, P. Thiyagarajan, R.E. Botto, S.C. Meredith, and D.G. Lynn Structure of the β-Amyloid (10-35) fibril J. Am. Chem. Soc. 122 2000 7883 7889
53. O.N. Antzutkin, J.J. Balbach, R.D. Leapman, N.W. Rizzo, J. Reed, and R. Tycko Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of β-sheets in Alzheimer's β-amyloid fibrils Proc. Natl. Acad. Sci. 97 2000 13045 13050
54. P.T. Lansbury, P.R. Costa, J.M. Griffiths, E.J. Simon, M. Auger, K.J. Halverson, D.A. Kocisko, Z.S. Hendsch, T.T. Ashburn, and R.G. Spencer Structural model for the betaamyloid fibril based on interstrand alignment of an antiparallel sheet comprising a C-terminal peptide Nat. Struct. Biol. 2 1995 990 998
55. 's β-amyloid peptide, and structural characterization by solid state NMR Biochemistry 39 2000 13748 13759
56. D.G. Lynn, and S.C. Meredith Review: model peptides and the physicochemical approach to β-amyloids J. Struct. Biol. 130 2000 153 173
57. M.D. Kirkitadze, M.M. Condron, and D.B. Teplow Identification and characterization of key kinetic intermediates in amyloid β-protein fibrillogenesis J. Mol. Biol. 312 2001 1103 1119
58. 16-22 amyloid peptide in to antiparallel β sheets Structures 11 2003 295 307
59. T. Härd, and C. Lendel Inhibition of amyloid formation J. Mol. Biol. 421 2012 441 465
60. X. Meng, L.A. Munishkina, A.L. Fink, and V.N. Uversky Molecular mechanisms underlying the flavonoid-induced inhibition of α-synuclein fibrillation Biochemistry 48 2009 8206 8224
61. M. Cavertino, R. Pellarin, M. Catto, A. Carotti, and A. Caflisch 9,10-anthraquinone hinders β-aggregation: how does a small molecule interfere with Aβ-peptide amyloid fibrillation Prot. Sci. 18 2009 792 800
62. E. Gazit A possible role of π-stacking in the self-assembly of amyloid fibrils FASEB J. 1 2002 77 83
63. L. Tjernberg, W. Hosia, N. Bark, J. Thyberg, and J. Johansson Charge attraction and beta propensity are necessary for amyloid fibril formation from tetrapeptide J. Biol. Chem. 277 2002 43243 43246
64. W.P. Esler, E.R. Stimson, J.R. Ghilardi, Y.A. Lu, A.M. Felix, H.V. Vinters, P.W. Mantyh, J.P. Lee, and J.E. Maggio Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence Biochemistry 35 1996 13914 13921
65. C. Wurth, N.K. Guimard, and M.H. Hecht Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis J. Mol. Biol. 319 2002 1279 1290
66. P. Sikorski, E.D.T. Atkins, and L.C. Serpell Structure and texture of fibrous crystals formed by Alzheimer's Aβ (11-25) peptide fragment Structures 11 2003 915 926
67. C.A. Hunter Aromatic-aromatic interactions: electrostatic or charge transfer? Angew. Chem. Int. Ed. 32 1993 1584 1586
68. Accelrys Software Inc. Discovery Studio Modeling Environment, Release 3.1 2011 Accelrys Software Inc. San Diego
69. A. Campbell Beta-amyloid: friend or foe Med. Hypotheses 56 2001 388 391
70. H.G. Lee, G. Casadesus, X. Zhu, J.A. Joseph, G. Perry, and M.A. Smith Perspectives on the amyloid-beta cascade hypothesis J. Alzheimers Dis. 6 2004 137 145
71. R. Kayed, E. Head, J.L. Thompson, T.M. McIntire, S.C. Milton, C.W. Cotman, and C.G. Glabe Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 2003 486 489
72. N. Reixach, S. Deechongkit, X. Jiang, J.W. Kelly, and J.N. Buxbaum Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture Proc. Natl. Acad. Sci. 101 2004 2817 2822
73. S. Lesné, M.T. Koh, L. Kotilinek, R. Kayed, C.G. Glabe, A. Yang, M. Gallagher, and K.H. Ashe A specific amyloid-beta protein assembly in the brain impairs memory Nature 440 2006 352 357
74. G.M. Shankar, S. Li, T.H. Mehta, A. Garcia-Munoz, N.E. Shepardson, I. Smith, F.M. Brett, M.A. Farrell, M.J. Rowan, C.A. Lemere, C.M. Regan, D.M. Walsh, B.L. Sabatini, and D.J. Selkoe Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Nat. Med. 14 2008 837 842
75. A.L. Gharibyan, V. Zamotin, K. Yanamandra, O.S. Moskaleva, B.A. Margulis, I.A. Kostanyan, and L.A. Morozova-Roche Lysozyme amyloid oligomers and fibrils induce cellular death via different apoptotic/necrotic pathways J. Mol. Biol. 365 2007 1337 1349
76. M. Meyer-Luehmann, T.L. Spires-Jones, C. Prada, M. Garcia-Alloza, A. de Calignon, A. Rozkalne, J. Koenigsknecht-Talboo, D.M. Holtzman, B.J. Bacskai, and B.T. Hyman Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease Nature 451 2008 720 724
77. L. Pieri, M. Bucciantini, D. Nosi, L. Formigli, J. Savistchenko, R. Melki, and M. Stefani The yeast prion Ure2p native-like assemblies are toxic to mammalian cells regardless of their aggregation state J. Biol. Chem. 281 2006 15337 15344
78. A.K. Paravastu, I. Qahwash, R.D. Leapman, S.C. Meredith, and R. Tycko Seeded growth of beta-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure Proc. Natl. Acad. Sci. 106 2009 7443 7448
79. S. Devanathan, Z. Salamon, G. Lindblom, G. Gröbner, and G. Tollin Effects of sphingomyelin, cholesterol and zinc ions on the binding, insertion and aggregation of the amyloid Abeta(1-40) peptide in solid-supported lipid bilayers FEBS J. 273 2006 1389 1402
80. I.C. Martins, I. Kuperstein, H. Wilkinson, E. Maes, M. Vanbrabant, W. Jonckheere, P. Van Gelder, D. Hartmann, R. D'Hooge, B. De Strooper, J. Schymkowitz, and F. Rousseau Lipids revert inert Abeta amyloid fibrils to neurotoxic protofibrils that affect learning in mice EMBO J. 27 2008 224 233
81. M.F. Engel, L. Khemtémourian, C.C. Kleijer, H.J. Meeldijk, J. Jacobs, A.J. Verkleij, B. de Kruijff, J.A. Killian, and J.W. Höppener Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane Proc. Natl. Acad. Sci. 105 2008 6033 6038
82. W. Xue, A.L. Hellewell, W.S. Gosal, S.W. Homans, E.W. Hewitt, and S.E. Radford Fibril fragmentation enhances amyloid cytotoxicity J. Biol. Chem. 284 2009 34272 34282
83. C. Holmes, D. Boche, D. Wilkinson, G. Yadegarfar, V. Hopkins, A. Bayer, R.W. Jones, R. Bullock, S. Love, J.W. Neal, E. Zotova, and J.A.R. Nicoll Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial Lancet 372 2008 216 223